Conditions: Rheumatoid Arthritis
Keywords: Rheumatoid Arthritis RA
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 155
Healthy volunteers: no

Brief summary:
This is a continuation trial of LymphoStat-B™ to evaluate the long-term safety in subjects with Rheumatoid Arthritis that completed study LBRA01 and benefitted from treatment.

Detailed description:
This is a multi-center, open label, continuation trial of LymphoStat-B™ in Rheumatoid Arthritis (RA) subjects who achieved at least an ACR20 response in the Phase 2 study LBRA01 (NCT00071812).

Arms:
arm 1: None

Interventions: intervention 1: belimumab
Intervention descriptions: intervention 1: IV 10mg/kg Q28 days

Protocol document: